Value-Added Products from Microalgae - Biotechnological Applications of Microalgae - page 157

Grima, E.M., Berlabi, E.-H., Acién Fernández, F.G., Robles Medina, A., and Chisti, Y. (2003).
Recovery of microalgal biomass and metabolites: process options and economics.
Biotechnology Advances, 20: 491-515.
Guedes, A.C., Amaro, H.M., and Malcata, F.X. (2011). Microalgae as sources of carotenoids.
Marine Drugs, 9: 625-644.
Halliday, J. (2006). Swiss Company Derives DHA and EPA from Algae. Online. Available
at <http://www.nutraingredients.com/Industry/Swiss-company-derives-DHA-and-EPA-
from-algae> (Accessed 29 July 2011).
Harun, R., Singh, M., Ford, G.M., and Danquah, M.K. (2010). Bioprocess engineering of
microalgae to produce a variety of consumer products, Renewable and Sustainable
Energy Reviews, 14: 1037-1047.
Heller, L. (2008). ZMC takes up position in lutein, zeaxanthin market. Online. Available at
<http://www.nutraingredients-usa.com/Industry/ZMC-takes-up-position-in-lutein-
zeaxanthin-market> (Accessed 05 April 2012).
Hempel, F., Lau, J., Klingl, A., and Maier, U.G. (2011). Algae as protein factories: Expression of
a human antibody and the respective antigen in the diatom Phaeodactylum tricornutum ,
Plos One, 6: 1-7.
Holub, B.J. (2011). DHA/EPA Omega-3 Fatty Acids for Human Health and Chronic
Disorders Insider Ingredients Volume 1: Issue 1. Online. Available at <http://
www.naturalproductsinsider.com/lib/download/asset-exploring-the-evolving-
market-for-long-chain-omega-3s.ashx?item_id={A9349DEE-989E-4AC5-B8FE-
F30D34078CEE}&item_name=digital_issue-exploring-the-evolving-market-for-long-
chain-omega-3s> (Accessed 29 July 2011).
Inbaraj, B.S., Chien, J.T., and Chen, B.H. (2006). Improved high performance liquid chromato-
graphic method determination of carotenoids in the microalga Chlorella pyrenoidosa .
Journal of Chromatography A, 1102: 193-199.
Jensen, A. (1993). Present and future needs for algae and algal products. Hydrobiologia,
260/261: 15-23.
Kim, S., Ravichandran, Y.D., Khan, S.B., and Kim, Y.T. (2008) Prospective of the cosmoceu-
ticals derived from marine organisms. Biotechnology and Bioprocess Engineering, 13:
511-523.
Kotake-Nara, E., and Nagao, A. (2011). Absorption and metabolism of xanthophylls. Marine
Drugs, 9: 1024-1037.
Kris-Etherton, P.M., Harris, W.S., and Appel, L.J. (for the AHA Nutrition Committee)
(2003). Omega-3 fatty acids and cardiovascular disease—New recommendations from
the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology,
23: 151-152.
Lee, Y.-K. (1997). Commercial productions of microalgae in the Asia-Pacific Rim. Journal of
Applied Phycology, 9: 403-411.
Lincoln, E.P. and Earle, J.F.K. (1990) Wastewater treatment with micro-algae. In: Akatsuka,
I. (Ed.), Introduction to Applied Phycology , SSPB Academic Publishing, The Hague,
pp. 429-446.
Luiten, E.E.M., Akkerman, I., Koulman, A., Kamermans, P., Reith, H., Barbosa, M.J.,
Sipkema, D., and Wijffels, T.H. (2003). Realising the promises of marine biotechnol-
ogy. Biomolecular Engineering, 20: 429-439.
life's DHA™ website (2012). Online. Available at <http://www.lifesdha.ca/-em-lifesdha-em.
aspx> (Accessed 9 March 2012).
Life Stages Benefits (2011). Meg-3. Online. Available at <http://www.meg-3.com/lifestages-
beneits> (Accessed 30 June 2011).
Market Opportunities (2011). Ocean Nutrition Canada. Online. Available at <http://www.
ocean-nutrition.com/omega3/market_opportunities> (Accessed 8 July 2011).